What does Dr. Karen De Coninck, dermatologie do?

Dr. Karen De Coninck, dermatologie is a specialist medical practice in Keerbergen. Private Limited, started on 28 December 1999, 1 establishment.

What is the address of Dr. Karen De Coninck, dermatologie?

The registered office of Dr. Karen De Coninck, dermatologie is located at Duivebergen 15, 3140 Keerbergen.

Is Dr. Karen De Coninck, dermatologie still active?

Yes. According to the CBE (31 October 2026) Dr. Karen De Coninck, dermatologie is active, legal situation “Normale toestand”, started on 28 December 1999.

Is Dr. Karen De Coninck, dermatologie registered on Peppol?

Yes, Dr. Karen De Coninck, dermatologie is registered on the Peppol network with ID 0208:0468915024.

What is the enterprise number of Dr. Karen De Coninck, dermatologie?

The enterprise number of Dr. Karen De Coninck, dermatologie is BE0468915024.

When was Dr. Karen De Coninck, dermatologie founded?

Dr. Karen De Coninck, dermatologie was founded on 28 December 1999.

Who are the directors of Dr. Karen De Coninck, dermatologie?

According to the 2025 annual accounts, the directors of Dr. Karen De Coninck, dermatologie are: Karen De Coninck.

Is Dr. Karen De Coninck, dermatologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Karen De Coninck, dermatologie make in 2025?

Dr. Karen De Coninck, dermatologie posted a profit after taxes of € 137,141 in financial year 2025.

What is the revenue of Dr. Karen De Coninck, dermatologie?

As a small company, Dr. Karen De Coninck, dermatologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 280,550.

Dr. Karen De Coninck, dermatologie (Private Limited)

Dossier Dr. Karen De Coninck, dermatologie, printed on 1 November 2026 from databakkes.be/en/0468915024/dr-karen-de-coninck-dermatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 8 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Karen De Coninck, dermatologie from Keerbergen, company number BE0468915024, closed financial year 2025 with a result of € 137,141 after tax. For that financial year Dr. Karen De Coninck, dermatologie recorded a gross margin of € 280,550 and equity of € 51,900. Compared with financial year 2024, the result moved from € 131,003 to € 137,141. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 20, 2026.

What it is worth Healthy

€ 51,900

▼ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 137,141

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,983

▲ 200% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 148,303 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 19,553

▲ 269% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 991,472

▼ 5% vs 2024

€ 131,378 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 15,140

▲ € 14,467 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 763

▼ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 265,411 Gross margin 2022: € 265,411 First fiscal year in the series	€ 298,792 Gross margin 2023: € 298,792 ▲ 13% vs 2022 (€ 265,411) Favourable step	€ 280,836 Gross margin 2024: € 280,836 ▼ 6% vs 2023 (€ 298,792) Unfavourable step	€ 280,550 Gross margin 2025: € 280,550 Unchanged (€ 280,836) Unfavourable step
Profit after taxes	€ 97,094 Profit after taxes 2022: € 97,094 First fiscal year in the series	€ 131,095 Profit after taxes 2023: € 131,095 ▲ 35% vs 2022 (€ 97,094) Favourable step	€ 131,003 Profit after taxes 2024: € 131,003 Unchanged (€ 131,095) Unfavourable step	€ 137,141 Profit after taxes 2025: € 137,141 ▲ 5% vs 2024 (€ 131,003) Favourable step	▲ 5%
Equity	€ 53,562 Equity 2022: € 53,562 First fiscal year in the series	€ 40,062 Equity 2023: € 40,062 ▼ 25% vs 2022 (€ 53,562) Unfavourable step	€ 63,062 Equity 2024: € 63,062 ▲ 57% vs 2023 (€ 40,062) Favourable step	€ 51,900 Equity 2025: € 51,900 ▼ 18% vs 2024 (€ 63,062) Unfavourable step	▼ 18%
Total debts	€ 1,303,366 Total debts 2022: € 1,303,366 First fiscal year in the series	€ 1,258,746 Total debts 2023: € 1,258,746 ▼ 3% vs 2022 (€ 1,303,366) Favourable step	€ 1,207,489 Total debts 2024: € 1,207,489 ▼ 4% vs 2023 (€ 1,258,746) Favourable step	€ 1,154,111 Total debts 2025: € 1,154,111 ▼ 4% vs 2024 (€ 1,207,489) Favourable step	▼ 4%
Cash	€ 7,899 Cash 2022: € 7,899 First fiscal year in the series	€ 9,263 Cash 2023: € 9,263 ▲ 17% vs 2022 (€ 7,899) Favourable step	€ 3,994 Cash 2024: € 3,994 ▼ 57% vs 2023 (€ 9,263) Unfavourable step	€ 11,983 Cash 2025: € 11,983 ▲ 200% vs 2024 (€ 3,994) Favourable step	▲ 200%
Land & buildings	€ 1,039,473 Land & buildings 2022: € 1,039,473 First fiscal year in the series	€ 1,014,167 Land & buildings 2023: € 1,014,167 ▼ 2% vs 2022 (€ 1,039,473) Unchanged	€ 990,497 Land & buildings 2024: € 990,497 ▼ 2% vs 2023 (€ 1,014,167) Unchanged	€ 966,827 Land & buildings 2025: € 966,827 ▼ 2% vs 2024 (€ 990,497) Unchanged	▼ 2%
Retained profit	€ 41,162 Retained profit 2022: € 41,162 First fiscal year in the series	€ 27,662 Retained profit 2023: € 27,662 ▼ 33% vs 2022 (€ 41,162) Unfavourable step	€ 50,662 Retained profit 2024: € 50,662 ▲ 83% vs 2023 (€ 27,662) Favourable step	€ 39,500 Retained profit 2025: € 39,500 ▼ 22% vs 2024 (€ 50,662) Unfavourable step	▼ 22%
Dividend	€ 97,094 Dividend 2022: € 97,094 First fiscal year in the series	€ 144,595 Dividend 2023: € 144,595 ▲ 49% vs 2022 (€ 97,094) Unchanged	€ 108,003 Dividend 2024: € 108,003 ▼ 25% vs 2023 (€ 144,595) Unchanged	€ 148,303 Dividend 2025: € 148,303 ▲ 37% vs 2024 (€ 108,003) Unchanged	▲ 37%
Bank debt	€ 1,203,047 Bank debt 2022: € 1,203,047 First fiscal year in the series	€ 1,124,217 Bank debt 2023: € 1,124,217 ▼ 7% vs 2022 (€ 1,203,047) Favourable step	€ 1,044,249 Bank debt 2024: € 1,044,249 ▼ 7% vs 2023 (€ 1,124,217) Favourable step	€ 991,472 Bank debt 2025: € 991,472 ▼ 5% vs 2024 (€ 1,044,249) Favourable step	▼ 5%
Balance sheet total	€ 1,356,928 Balance sheet total 2022: € 1,356,928 First fiscal year in the series	€ 1,298,808 Balance sheet total 2023: € 1,298,808 ▼ 4% vs 2022 (€ 1,356,928) Unchanged	€ 1,270,551 Balance sheet total 2024: € 1,270,551 ▼ 2% vs 2023 (€ 1,298,808) Unchanged	€ 1,206,011 Balance sheet total 2025: € 1,206,011 ▼ 5% vs 2024 (€ 1,270,551) Unchanged	▼ 5%

Key figures of Dr. Karen De Coninck, dermatologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Karen De Coninck, dermatologie?

What happened at Dr. Karen De Coninck, dermatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 20, 2026 New annual accounts for financial year 2025: profit of € 137,141 (▲ 5% vs 2024). filed late Source: NBB ↗
2019 Karen De Coninck became a director. NBB
Jan 1, 2013 New establishment in Boortmeerbeek. KBO
Dec 28, 1999 Start of the company according to the CBE. KBO

In short

From € 97,094 profit in 2022 to € 137,141 profit in 2025.

Paid € 155,558 in corporate taxes since 2022.

Best year ever: 2025, with € 137,141 profit.

Paid out € 497,995 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Karen De Coninck

Dr. Karen De Coninck, dermatologie

Behind Dr. Karen De Coninck, dermatologie is Karen De Coninck.

Directors

According to the 2025 annual accounts

Karen De Coninck

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Duivebergen 15

3140 Keerbergen

2.220.165.494

Bredepleinstraat 1 box A

3190 Boortmeerbeek

Active since 1 January 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0468.915.024

VAT number

BE 0468.915.024

Registered office

Duivebergen 15, 3140 Keerbergen

Names & denominations

Dr. Karen De Coninck, dermatologie

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 December 1999

Peppol

Active · Active since 10 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Schoonheidsverzorging en andere schoonheidsbehandelingen

Schoonheidsverzorging

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Karen De Coninck, dermatologie

Warning lights

Financials

What happened to Dr. Karen De Coninck, dermatologie?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions